Clinical Trial Update: A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update for subcutaneous fitusiran to prevent bleeding episodes in males with severe hemophilia, with the study currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Fitusiran (fitusiran)

Snippet

Sponsor: Sanofi | Conditions: Hemophilia | Phase 3 | Status: ACTIVE_NOT_RECRUITING